What is the translation of " RECOMBINANT FACTOR " in Croatian?

• rekombinantnog faktora

Examples of using Recombinant factor in English and their translations into Croatian

Recombinant factor VIIa(r-FVIIa) can also be considered.
Može se razmotriti i primjena rekombinantnog faktora VIIa r-FVIIa.

Currently there is no experience with the use of recombinant factor VIIa in individuals receiving apixaban.
Trenutno nema iskustva s primjenom rekombinantnog faktora VIIa u bolesnika koji primaju apiksaban.

Re-dosing of recombinant factor VIIa shall be considered and titrated depending on improvement of bleeding.
Razmotrit će se ponovno doziranje rekombiniranog faktora VIIa i titriranje ovisno o poboljšanju krvarenja.

Coagulation factor concentrates(activated or non-activated) or recombinant Factor VIIa may be taken into account.
U obzir se mogu uzeti koncentrati koagulacijskih faktora(aktivirani ili neaktivirani) ili rekombinantni faktor VIIa.

Re-dosing of recombinant factor VIIa could be considered and titrated depending on improvement of bleeding.
Može se razmotriti višekratno doziranje i titriranje doze rekombinantnog faktora VIIa ovisno o poboljšanju krvarenja.

Antifibrinolytic therapy(aminocaproic acid or tranexamic acid) and/or recombinant factor VIIa therapy may increase haemostasis.
Antifibrinolitička terapija(aminokaproična i traneksamična kiselina) i/ili terapija rekombinantnim faktorom VIIa mogu povećati hemostazu.

The recombinant factor IX portion is identical to the Thr148 allelic form of plasma- derived factor IX.
Dio koji čini rekombinantni faktor IX identičan je alelnom obliku Thr148 faktora IX dobivenog iz plazme.

If life-threatening bleeding cannot be controlled by the above measures, administration of prothrombin complex concentrates(PCCs) or recombinant factor VIIa may be considered.
Ako se krvarenje koje ugrožava život bolesnika ne može staviti pod kontrolu prethodno navedenim mjerama, treba razmotriti primjenu koncentrata protrombinskog kompleksa(PCC-ova) ili rekombinantnog faktora VIIa.

Since oktokog alpha contains only recombinant factor VIII, it is not intended to treat patients with von Willebrand's disease.
Jer oktokog sadrži samo alfa rekombinantni čimbenik VIII, Nije namijenjen za liječenje bolesnika s von Willebrand bolesti.

EMA will now evaluate data from the recent study together with all other relevant data on blood-derived and recombinant factor VIII medicines.
Pri EMA-i će se ocijeniti podaci iz navedenog istraživanja, zajedno sa svim drugim relevantnim podacima o lijekovima čije su djelatne tvari rekombinantni koagulacijski faktor VIII i koagulacijski faktor VIII dobiven iz ljudske krvi.

One IU of recombinant factor VIII Fc activity is equivalent to that quantity of factor VIII in one mL of normal human plasma.
Jedna IU aktivnosti rekombinantnog faktora VIII Fc odgovara količini faktora VIII u jednom ml normalne ljudske plazme.

If bleeding cannot be controlled by the above measures, administration of a specific procoagulant reversal agent should be considered, such as prothrombin complex concentrate(PCC), activated prothrombin complex concentrate(APCC) or recombinant factor VIIa r-FVIIa.
Ako se krvarenje ne može kontrolirati gore navedenim mjerama, mora se razmotriti primjena specifičnog agensa za poticanje zgrušnjavanja poput koncentrata protrombinskog kompleksa, aktiviranog koncentrata protrombinskog kompleksa ili rekombinantnog faktora VIIa r-FVIIa.

The cleavable linker between the recombinant factor IX and albumin molecules is derived from the endogenous“activation peptide” in native factor IX.
Raskidiva poveznica između molekule rekombinantnog faktoraIX i molekule albumina dobivena je od endogenog“aktivacijskog peptida” u nativnom faktoru IX.

As one PTP treated with BeneFIX developed a clinically relevant low responding inhibitor during clinical studies and experience on antigenicity with recombinant factor IX is still limited, patients treated with BeneFIX should be carefully monitored for the development of factor IX inhibitors that should be titrated in Bethesda Units using appropriate biological testing.
Budući da je jedan prethodno liječeni bolesnik liječen BeneFIX-om razvio klinički značajan inhibitor sa slabim odgovorom tijekom kliničkih ispitivanja, a iskustvo s antigenošću rekombinantnog faktoraIX još je ograničeno, bolesnike liječene BeneFIX-om treba pažljivo pratiti zbog razvoja inhibitora faktora IX, čiji titar treba mjeriti u Bethesda jedinicama pomoću odgovarajućeg biološkog testa.

The number of units of recombinant factor IX Fc administered is expressed in International Units(IU), which are related to the current WHO standard for factor IX products.
Broj primijenjenih jedinica rekombinantnog faktora IX Fc izražava se u međunarodnim jedinicama(IU), koje su u skladu s važećim standardom SZO za lijekove s faktorom IX.

Efmoroctocog alfa recombinant coagulation factor VIII.
Efmoroktokog alfa(efmoroctocog alfa) rekombinantni faktor zgrušavanja krvi VIII.

NovoSeven contains activated recombinant coagulation factor VII.
NovoSeven sadrži aktivirani rekombinantni koagulacijski faktor VII.

Eftrenonacog alfa recombinant coagulation factor IX IV.
Eftrenonacog alfa rekombinantni faktor zgrušavanja krvi IX i.v.

RIXUBIS contains recombinant coagulation factor IX nonacog gamma.
RIXUBIS sadrži rekombinantni koagulacijski faktor IX nonakog gama.

Nonacog alfa(recombinant coagulation factor IX) Intravenous use.
Nonakog alfa(rekombinantni koagulacijski faktor IX) Primjena u venu.

Recombinant coagulation factor VIII(octocog alfa) Intravenous use.
Rekombinantni koagulacijski faktor VIII(oktokog alfa) Primjena u venu.

BeneFIX contains recombinant coagulation factor IX, INN nonacog alfa.
BeneFIX sadrži rekombinantni koagulacijski faktor IX, INN nonakog alfa.

The active substance is nonacog alfa recombinant coagulation factor IX.
Djelatna tvar je nonakog alfa rekombinantni koagulacijski faktor IX.

The active substance is moroctocog alfa recombinant coagulation factor VIII.
Djelatna tvar je moroktokog alfa rekombinantni koagulacijski faktor VIII.

The active substance is recombinant coagulation factor VIIa activated eptacog alfa.
Djelatna tvar je rekombinantni koagulacijski faktor VIIa eptakog alfa, aktivirani.

ReFacto AF contains B-domain deleted recombinant coagulation factor VIII moroctocog alfa.
ReFacto AF sadrži rekombinantni koagulacijski faktor VIII bez B-domene moroktokog alfa.

Each vial contains nominally 1000 IU nonacog alfa recombinant coagulation factor IX.
Jedna bočica sadrži nominalno 1000 IU nonakoga alfa rekombinantnog koagulacijskog faktora IX.

Nuwiq contains the active substance human recombinant coagulation factor VIII simoctocog alfa.
Nuwiq sadrži djelatnu tvar ljudski rekombinantni koagulacijski faktor VIII simoktokog alfa.

No symptoms of overdose have been reported with recombinant coagulation factor VIII products.
Nije zabilježen nijedan simptom predoziranja s lijekovima s rekombinantnim koagulacijskim faktorom VIII.

No symptoms of overdose have been reported with recombinant coagulation factor IX products.
Nisu prijavljeni simptomi predoziranja s lijekovima koji sadrže rekombinantni koagulacijski faktor IX.